SNIFFED: Steroid Nasal Irrigation for Flavor Evaluation and Detection Study

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02985515
Collaborator
(none)
31
1
1
37.7
0.8

Study Details

Study Description

Brief Summary

The purpose of this research study is to examine the efficacy of a 12-week smell training intervention for participants with olfactory dysfunction following an infection of the upper respiratory tract.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Smell training
Phase 4

Detailed Description

Olfactory dysfunction affects up to fifteen percent of the general population and can cause significant psychosocial distress including decreased appetite, reduced self-hygiene, and mood disturbances.

This study aims to study the efficacy of smell training for patients with olfactory dysfunction following a viral upper respiratory tract infection. Eligible participants will complete a 30-day course of budesonide nasal saline irrigation. Participants who do not show improvement in their olfaction based on composite smell and taste tests will be eligible to receive a baseline resting-state fMRI (rs-fMRI) and complete a 12-week smell training intervention program. Smell training involves participants smelling 4 odors (phenyl ethyl alcohol, eucalyptus, lemon, and eugenol) twice a day for 12 weeks. Following completion of smell training, participants will undergo repeat smell and taste tests as well as rs-fMRI to ascertain the efficacy of smell training.

Study Design

Study Type:
Interventional
Actual Enrollment :
31 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Steroid Nasal Irrigation for Flavor Evaluation and Detection (SNIFFED) Study
Actual Study Start Date :
Sep 28, 2016
Actual Primary Completion Date :
Nov 20, 2019
Actual Study Completion Date :
Nov 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Smell Training

Participants will first undergo a 30-day trial of budesonide nasal saline irrigation. If there is no subsequent improvement in olfaction, participants will undergo a 12-week smell training intervention.

Combination Product: Smell training
Eligible participants will be provided with a "NeilMed" Sinus Rinse Regular Bottle Kit and a one-month supply of USP Grade Sodium Chloride & Sodium Bicarbonate Mixture commercially prepared packets. Participants will need to purchase distilled water or boil tap water for five minutes for use with the saline irrigation. The contents of two capsules (0.5mg budesonide each) will be dissolved into "NeilMed" Sinus Rinse Regular Bottle along with the saline rinse. Both nasal cavities will be irrigated once daily for 30 days. Participants who do not have objective improvement in their olfaction after the trial of budesonide irrigation will have a baseline resting-state fMRI (rs-fMRI) and undergo 12 weeks of smell training. Smell training involves the participants smelling 4 vials of essential odors twice a day for 12 weeks. Following smell training, participants will have their smell ability re-evaluated and a second rs-fMRI performed.

Outcome Measures

Primary Outcome Measures

  1. Pre- and post-intervention difference in smell testing before and after smell training intervention [12 weeks]

    Objective pre- and post-intervention differences of participant performance on the UPSIT and Sniffin Sticks tests, validated psychosocial instruments, before and after smell intervention training will be obtained.

  2. Pre- and post-intervention difference in neuroplasticity before and after smell training [12 weeks]

    Baseline and post-intervention connectivity in and between regions of interest in the olfactory and olfactory related networks using resting state fMRI will be obtained.

Secondary Outcome Measures

  1. Pre- and post-intervention difference in smell testing before and after budesonide treatment [30 days]

    Objective pre- and post-intervention differences of participant performance on the UPSIT and Sniffin Sticks tests before and after budesonide saline nasal irrigation

  2. Subjective response of budesonide nasal saline irrigation [30 days]

    Participants will be asked to fill out an intervention-specific form (Clinical Global Impression) rating how they feel they've responded to budesonide treatment from "Excellent" response to "Poor" response to budesonide nasal saline irrigation. This provides a subjective measurement to go along with the study's objective measures of smell and taste test performance.

  3. Subjective response to smell training intervention [12 weeks]

    Participants will be asked to fill out an intervention-specific form (Clinical Global Impression) rating how they feel they've responded to smell training from "Excellent" response to "Poor" response to smell training intervention. This provides a subjective measurement to go along with the study's objective measures of smell and taste test performance.

  4. Characterization of olfactory network in healthy controls [1 week]

    Baseline functional connectivity within and between the olfactory and associated networks of healthy controls will be compared to that of study participants as measured by rs-fMRI.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age between 18 and 70

  • Anosmia or hyposmia (UPSIT <34 (male), UPSIT <34 (female); Sniffin' Sticks threshold below 5.5)

Exclusion Criteria:
  • Inability to understand English

  • Current smoker or history of smoking within the past 6 months

  • Current nasal polyps

  • Exposure to head and or/neck radiation

  • Exposure to chemotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT02985515
Other Study ID Numbers:
  • 201608163
First Posted:
Dec 7, 2016
Last Update Posted:
Feb 5, 2020
Last Verified:
Feb 1, 2020
Keywords provided by Washington University School of Medicine

Study Results

No Results Posted as of Feb 5, 2020